Timothy Alexander

Philadelphia Zoo Unveils Stunning Spring ZooTopiaries and Garden Experiences PHILADELPHIA, PA — Spring isn’t just blooming at the Philadelphia Zoo—it’s coming to life in larger-than-life ways. From towering living sculptu […]

EnerSys to Host Investor Day at NYSE on June 11 READING, PA — EnerSys (NYSE: ENS) said it will host an Investor Day on Thursday, June 11, 2026, at the New York Stock Exchange, where executives will o […]

Nordic Cold Chain Opens Lab for GLP-1 Packaging Solutions HATFIELD, PA — Nordic Cold Chain Solutions announced the launch of a GLP-1 and small-format packaging innovation lab to support the development and s […]

Quavo Launches AI Tool for Financial Dispute Management WILMINGTON, DE — Quavo, Inc. announced the launch of Aria, an artificial intelligence tool designed to automate and manage dispute resolution p […]

Solana Company Reports Q4 Profit Amid Digital Asset Volatility NEWTOWN, PA — Solana Company (Nasdaq: HSDT) recenlty reported fourth-quarter net income of $325.6 million for 2025, driven by gains on derivative l […]

Signature Systems Partners With Muscogee Nation Casinos on POS Rollout WARMINSTER, PA — Signature Systems, Inc. said it has partnered with Muscogee (Creek) Nation Casinos to deploy its PDQ point-of-sale system across m […]

Aprea Reports Partial Response in APR-1051 Cancer Trial DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) reported a confirmed partial response in its ongoing Phase 1 clinical trial evaluating A […]

SEED Therapeutics to Present Neuroblastoma Data at AACR Meeting KING OF PRUSSIA, PA — SEED Therapeutics, Inc. said it will present research on an RBM39 degrader targeting neuroblastoma at the 2026 American A […]

Philadelphia’s Yards Brewing Unveils Exclusive ‘America 250’ Beer for Craft Brewers Conference PHILADELPHIA, PA — Imagine raising a glass that tells the story of 250 years of American history—that’s exactly what Philadelphia beer lovers will […]

Palvella Publishes Review on Lymphatic Malformations in Medical Journal WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the publication of a review article in the Journal of Vascular Anomalies examining c […]

Colonial Theatre Unveils Spring Event Lineup PHOENIXVILLE, PA — The Colonial Theatre will host a slate of live music, comedy, and cultural events throughout April and May, offering a diverse s […]

Where We Danced: The Night Exton Became Immortal The screen glowed against the summer dark, a white rectangle cutting through the humid July air as headlights flickered and engines idled in loose rows […]

Where Your $2 Goes: Supporting Chester County News Local journalism in Chester County is at a crossroads. Across Pennsylvania and beyond, traditional newsrooms are shrinking as advertising revenue […]

Medicus Pharma Submits Phase 2 Protocol for Teverelix to FDA PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) said it has submitted an optimized Phase 2 clinical trial protocol to the U.S. Food and Drug A […]

Norristown’s Theatre Horizon Swings Into Spring With ‘Ain’t Misbehavin’’ NORRISTOWN, PA — The rhythm of jazz, the energy of live performance, and the spirit of the Harlem Renaissance are set to light up Norristown as T […]

A. Duie Pyle Wins ATA President’s Trophy in Large Carrier Debut WEST CHESTER, PA — A. Duie Pyle, a transportation and logistics company headquartered in West Chester, was named a winner of the American Trucking A […]

Incyte Drug Shows Reduced COPD-like HS Flares in Phase III Data WILMINGTON, DE — Incyte (Nasdaq: INCY) reported 54-week Phase III data showing its experimental drug povorcitinib reduced disease activity in p […]

Mid Penn Bank Expands Philadelphia Presence With Key Hire in Newtown NEWTOWN, PA — Mid Penn Bank strengthened its commercial lending team in the greater Philadelphia market with the addition of Andrew McGinnis as vice p […]

Teleflex Responds to Irenic, Reaffirms Strategy and Asset Sales WAYNE, PA — Teleflex Incorporated (NYSE: TFX) said it remains focused on completing previously announced asset sales and pursuing its strategic plan a […]

AstraZeneca Drug Cuts COPD Exacerbations in Phase III Trials WILMINGTON, DE — AstraZeneca (NYSE: AZN) said its experimental drug tozorakimab reduced moderate-to-severe exacerbations in patients with chronic o […]